Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of dengue virus infection

M. Namekar, E.M. Ellis, M. O'Connell, J.L.S.B. Elm, A. Gurary, S.Y. Park, Allison Imrie, V.R. Nerurkar

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)

Abstract

We evaluated the FDA-cleared InBios dengue virus (DENV) IgM capture enzyme-linked immunosorbent assay (ELISA) for qualitative detection of anti-DENV IgM antibodies from 79 serum samples obtained from dengue virus-infected patients or suspected dengue cases. The agreement, sensitivity, and specificity of the InBios assay compared to the gold standard in-house DENV IgM capture ELISA were 94, 92, and 94%, respectively. We conclude that the InBios DENV IgM capture ELISA can be effectively used for rapid diagnosis of acute or recent DENV infection. Copyright © 2013, American Society for Microbiology. All Rights Reserved.
Original languageEnglish
Pages (from-to)3102-3106
JournalJournal of Clinical Microbiology
Volume51
Issue number9
DOIs
Publication statusPublished - 2013

Fingerprint

Dive into the research topics of 'Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of dengue virus infection'. Together they form a unique fingerprint.

Cite this